Cymabay Therapeutics 

€0.000000
276
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

2SepExpected
Q1 2026
Next
-0.05
-0.04
-0.03
-0.02
Expected EPS
-0.0173849208
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow C0I.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
NextEra Energy
NEE
Mkt Cap184.24B
NextEra Energy, Inc. is a leading clean energy company, directly competing in the renewable energy sector with Via Renewables.
Duke Energy
DUK
Mkt Cap101.04B
Duke Energy Corporation operates in the electric power and gas distribution sectors, offering renewable energy solutions that compete with Via Renewables.
Southern Company
SO
Mkt Cap110.45B
Southern Company is involved in the generation and distribution of electricity, including renewable energy sources, making it a competitor.
Exelon
EXC
Mkt Cap48.99B
Exelon Corporation is a major player in the energy sector, with a significant focus on clean energy, competing with Via Renewables.
Dominion Energy
D
Mkt Cap61.35B
Dominion Energy, Inc. provides electricity and natural gas to customers, with a growing portfolio in renewable energy.
Public Service Enterprise Group
PEG
Mkt Cap40.67B
Public Service Enterprise Group Incorporated operates in the energy sector, with investments in renewable energy projects.
American Electric Power Company
AEP
Mkt Cap75.36B
American Electric Power Company, Inc. is a major electric utility company, with a focus on clean energy, including renewables.
Xcel Energy
XEL
Mkt Cap51.17B
Xcel Energy Inc. is an electric and natural gas utility company, with a strong emphasis on renewable energy sources.
AES
AES
Mkt Cap10.4B
The AES Corporation is a global power company, with a significant portion of its portfolio dedicated to renewable energy.
NRG Energy
NRG
Mkt Cap28.84B
NRG Energy, Inc. is an integrated power company, with operations in electricity generation, including renewable energy, competing with Via Renewables.

About

Via Transportation, Inc. delivers digital platforms for public mobility across the United States, Germany, and other international markets. Central to its offerings is "TransitTech," a specialized public mobility platform designed to empower partners in establishing comprehensive, integrated transit systems. This involves expert planning and scheduling to seamlessly weave multiple transportation modes into a unified network. The company provides tailored solutions for various sectors, including flexible on-demand microtransit, paratransit, student transport, non-emergency medical journeys (NEMT), corporate and university shuttle services, and broader health-related travel. Via's extensive client roster includes cities, public transit authorities and operators, paratransit providers, educational institutions (from school districts to universities), private corporations, healthcare organizations, and ultimately serves both passengers and drivers. Established in 2012, the firm maintains its headquarters in New York, New York.
Show more...
CEO
Mr. Daniel Ramot
Employees
973
Country
United States
ISIN
US23257D1037

Listings

0 Comments

Share your thoughts

FAQ

What is Cymabay Therapeutics stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Cymabay Therapeutics stocks are traded under the ticker C0I.MU.
When is the next Cymabay Therapeutics earnings date?
Cymabay Therapeutics is going to release the next earnings report on September 02, 2026.
What were Cymabay Therapeutics earnings last quarter?
C0I.MU earnings for the last quarter are -0.04 EUR per share, whereas the estimation was -0.05 EUR resulting in a +16.12% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Cymabay Therapeutics have?
As of July 09, 2026, the company has 973 employees.
In which sector is Cymabay Therapeutics located?
Cymabay Therapeutics operates in the Manufacturing sector.
When did Cymabay Therapeutics complete a stock split?
Cymabay Therapeutics has not had any recent stock splits.
Where is Cymabay Therapeutics headquartered?
Cymabay Therapeutics is headquartered in New York, United States.